Eden Research plc (EDEN) - Total Liabilities

Latest as of June 2025: GBX2.85 Million GBX ≈ $347.13 USD

Based on the latest financial reports, Eden Research plc (EDEN) has total liabilities worth GBX2.85 Million GBX (≈ $347.13 USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Eden Research plc (EDEN) long-term investment share to see how much of total assets are deployed in long-term investments.

Eden Research plc - Total Liabilities Trend (2004–2024)

This chart illustrates how Eden Research plc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see EDEN asset base.

Eden Research plc Competitors by Total Liabilities

The table below lists competitors of Eden Research plc ranked by their total liabilities.

Company Country Total Liabilities
JDC Group AG
XETRA:JDC
Germany €174.34 Million
Mineral & Financial Investments Ltd
LSE:MAFL
UK GBX518.00K
ImmuPharma PLC
LSE:IMM
UK GBX1.24 Million
Rua Life Sciences PLC
LSE:RUA
UK GBX1.89 Million
Artisanal Spirits Company PLC
LSE:ART
UK GBX40.89 Million
Vicarious Surgical Inc.
NYSE:RBOT
USA $9.02 Million

Liability Composition Analysis (2004–2024)

This chart breaks down Eden Research plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Eden Research plc balance sheet quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.17 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.27 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.21 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Eden Research plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Eden Research plc (2004–2024)

The table below shows the annual total liabilities of Eden Research plc from 2004 to 2024.

Year Total Liabilities Change
2024-12-31 GBX3.57 Million
≈ $434.15
+17.03%
2023-12-31 GBX3.05 Million
≈ $370.97
+40.59%
2022-12-31 GBX2.17 Million
≈ $263.86
-1.32%
2021-12-31 GBX2.20 Million
≈ $267.39
+10.13%
2020-12-31 GBX2.00 Million
≈ $242.78
+31.53%
2019-12-31 GBX1.52 Million
≈ $184.59
+60.90%
2018-12-31 GBX942.87K
≈ $114.72
-54.49%
2017-12-31 GBX2.07 Million
≈ $252.10
+100.63%
2016-12-31 GBX1.03 Million
≈ $125.66
+37.23%
2015-12-31 GBX752.55K
≈ $91.56
+64.20%
2014-12-31 GBX458.30K
≈ $55.76
-46.34%
2013-12-31 GBX854.09K
≈ $103.92
-59.22%
2012-12-31 GBX2.09 Million
≈ $254.86
-27.97%
2011-12-31 GBX2.91 Million
≈ $353.82
-48.77%
2010-12-31 GBX5.68 Million
≈ $690.61
+37.80%
2009-12-31 GBX4.12 Million
≈ $501.16
+24.44%
2008-12-31 GBX3.31 Million
≈ $402.72
+19.83%
2007-12-31 GBX2.76 Million
≈ $336.09
-14.34%
2006-12-31 GBX3.22 Million
≈ $392.36
+45.99%
2005-12-31 GBX2.21 Million
≈ $268.76
+96.65%
2004-12-31 GBX1.12 Million
≈ $136.66
--

About Eden Research plc

LSE:EDEN UK Agricultural Inputs
Market Cap
$205.27K
GBX1.69 Billion GBX
Market Cap Rank
#31327 Global
#1026 in UK
Share Price
GBX2.10
Change (1 day)
+5.00%
52-Week Range
GBX2.00 - GBX4.80
All Time High
GBX20.25
About

Eden Research plc, together with its subsidiaries, engages in the development and sale of biopesticides in Europe and the United Kingdom. The company offers foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatments under the Mevalone and Cedroz brands for crop protection applications. It also provides consume products, such a… Read more